Qiangsen Medical Secures Hundreds of Millions in Series C Funding from Sunac China to Advance Urban Healthcare Infrastructure Collaboration

VCBeat learned that on November 26, 2020, Johnson Medical officially announced the completion of its Series C financing round, amounting to hundreds of millions of yuan, with strategic investment from Sunac China. The signing ceremony for this strategic investment partnership was held at the headquarters of Johnson Medical Group. Leaders from the Xi’an Municipal Health Commission, Xixian New Area, and Fengdong New City Management Committee; Wang Mengde, Executive Director and CEO of Sunac China; Cao Hongling, Executive Director and CEO of Sunac Services Group; Xie Jianjun, Vice President of Sunac Services Group; Ma Li, General Manager of the Strategic Investment Department of Sunac China; and He Haiyang, Founder and CEO of Johnson Medical, jointly witnessed the signing.

Sunac China Holdings Limited is a company listed on the Main Board of The Stock Exchange of Hong Kong. With real estate as its core business, it has implemented a comprehensive “Real Estate+” strategy, encompassing six strategic segments including Sunac Real Estate, Sunac Services, and Sunac Medical and Elderly Care. It is an industry leader in terms of community property management scale, urban footprint, and service quality. Johnson Medical focuses on community-based general practice, centering on health and guided by digitalization and smart technologies. It builds a chained medical ecosystem integrating “cloud + terminal + products + services,” providing high-quality and convenient general practice and family doctor services tailored to the full-scenario needs of community households, enterprises, and public institutions.

The successful signing of this strategic cooperation agreement marks a commitment by both parties to fully leverage their respective strengths and achieve resource complementarity, jointly promoting an integrated industrial development model. The two sides will engage in comprehensive collaboration in the fields of urban medical support services and healthcare/elderly care, with seamless integration particularly in community medical facilities, elderly care infrastructure, family health management, and internet-based healthcare, thereby jointly exploring new frontiers in integrated industry operations.

He Haiyang, Founder and CEO of Johnson Medical, stated that the market for community-based general practice services is still in its nascent stage, with significant untapped potential in every regional market. The rapid penetration into terminal hospitals represents a unique advantage of this partnership. Terminal hospitals serve as the exclusive pathway for implementing "community first-contact care," whose successful execution is pivotal to the success of the current healthcare reform's "tiered diagnosis and treatment" policy. Following the completion of this funding round, we will intensify our efforts in clinic expansion and product R&D, continuously building a closed-loop healthcare service ecosystem aligned with our strategy of "agile frontline, robust platform, and rich ecosystem."

He Haiyang introduced that, under the model of integrated industrial development, better business operations require implementing five additional “+” strategies: the “Clinic + Community” convenient care model, the “Prevention + Treatment” general practice model, the “Community Healthcare + Home-based Elderly Care” medical-nursing integration model, the “Family Doctor + Health Management” membership model, and the “Offline + Online” ecosystem model. These efforts aim to establish an integrated, full-cycle healthcare management service encompassing “Hospital–Community–Home” and “Pre-diagnosis–During Diagnosis–Post-diagnosis.”

Wang Mengde, Executive Director and CEO of Sunac China, stated that Sunac is optimistic about Xi’an, the medical and health-care industry, and the Johnson Medical team. The current social structure has raised higher demands for healthcare, necessitating the supply side to deliver higher-quality services and products. Johnson Medical’s product positioning aligns with people’s actual needs and also resonates with Sunac’s corporate identity as a co-builder of better cities. Looking ahead, Sunac will adopt a long-term perspective to continuously invest in and strategically position itself within the medical and health-care sector.

Wang Jianfei, Managing Director at Legend Capital, stated that as one of the early investors, Legend Capital has witnessed Johnson’s development and growth. Johnson was among the first companies in the industry to recognize the importance of digital tools for general practice medical layout. The company independently developed a Medical Assistant SaaS platform product, structured data from both B-end and C-end users, and integrated all aspects of “Internet + Healthcare Services.” This has resulted in a comprehensive, closed-loop cloud-based healthcare service solution encompassing video consultations, medication delivery, online medical advice, in-home nursing services, patient reviews, and health big data, demonstrating strong R&D and innovation capabilities. We will continue to firmly support Johnson’s future development.

Discussing the development goals for the next phase, He Haiyang stated that Johnson & Johnson will launch its next five-year plan, focusing on strategic deployment in five major central cities—Xi’an, Chengdu, Chongqing, Wuhan, and Zhengzhou—while extending its reach to other central cities across China. Meanwhile, Johnson & Johnson will also intensify its efforts in digital healthcare, leveraging digital technology to empower the future of medical care. With the advent of the 5G era, Johnson & Johnson’s “cloud + terminal” model is expected to demonstrate greater value. Combined with Sunac’s nationwide scale and quality advantages, this will usher in broader development opportunities.